Cell Culture Reagents

The gene KCNMB3 (calcium-activated potassium channel subunit &#946-3) is mapped to human chromosome 3q26.3-q27.

Immunogen potassium channel subfamily M regulatory beta subunit 4 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most

Potassium voltage-gated channel subfamily Q member 2 (KCNQ2) gene, which codes for voltage-gated potassium channel subunits, is mostly expressed in the brain. KCNQ2 is made up of heteromultimeric channels with six transmembrane domains (S1–S6) in

Immunogen potassium voltage-gated channel, KQT-like subfamily, member 2 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most

KCNS3 (potassium voltage-gated channel, modifier subfamily S, member 3) codes for the modulatory &#945-subunit of Kv9.3 votlage-gated potassium channel.

Potassium sodium-activated channel subfamily T member 2 (KCNT2), also known as SLO2.1, is a Na + -activated K + (K Na ) channel.

The KCNV2 (potassium channel, subfamily V, member 2) gene is mapped to human chromosome 9p24.2.

Immunogen potassium channel tetramerization domain containing 1 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most

Immunogen potassium channel tetramerization domain containing 1 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most

The gene KCTD10 (potassium channel tetramerization domain containing 10) is mapped to human chromosome 12q24.11 and contains seven exons.

Immunogen potassium channel tetramerisation domain containing 11 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project

KCTD13 (potassium channel tetramerization domain containing 13) codes for the polymerase delta-interacting protein 1 (PDIP1). It is expressed in the developing brain.